CAU
WST icon

Caxton Associates (UK)’s West Pharmaceutical WST Stock Holding History

Caxton Associates (UK)’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.39M Buy
3,866
+2,409
+165% +$737K 0.03% 345
2026
Q1 		$365K Buy
+1,457
New +$363K 0.01% 560
2025
Q3 		– Sell
-7,360
Closed -$1.61M – 954
2025
Q2 		$1.61M Buy
+7,360
New +$1.57M 0.04% 232

Other funds holding WST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Caxton Associates (UK)'s WST Position: Q2 2026 in Review

Caxton Associates (UK) increased its West Pharmaceutical (WST) stake by 165% in Q2 2026, buying an estimated $737K and bringing the position to 3,866 shares worth $1.39M. The position accounts for 0.03% of the portfolio, ranked #345.

Caxton Associates (UK) first reported a position in WST in Q2 2025 and has held it in 3 quarters since. The position peaked at $1.61M in Q2 2025. 831 funds tracked by Wall St. Rank hold WST as of Q2 2026.

  • Caxton Associates (UK) held 3,866 shares of West Pharmaceutical worth $1.39M as of Q2 2026.
  • Caxton Associates (UK) bought 2,409 West Pharmaceutical shares in Q2 2026, an estimated $737K.
  • West Pharmaceutical made up 0.03% of Caxton Associates (UK)'s portfolio in Q2 2026, its #345 holding.
  • Caxton Associates (UK) first reported a position in West Pharmaceutical in Q2 2025 and has held it in 3 quarters since.
  • Caxton Associates (UK)'s West Pharmaceutical position peaked at $1.61M in Q2 2025.
  • 831 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on Caxton Associates (UK)'s 13F filing for Q2 2026, filed 14 Aug 2026.